Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

Avinger raises $25 million for catheter development and commercialization

Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating peripheral artery disease (PAD), recently completed a $25 million Series B round of funding from a syndicate of highly successful entrepreneurs and executives.

12 Jan 2011

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Boehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

12 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Vitamin drinks contain too much sugar: CHOICE review

According to consumer group CHOICE the available vitamin-enhanced water products, produced by such companies as Nutrient Water, Smart Water and Vitamin Water, often contain high levels of sugar and in some cases were branded in a way that suggested they contained ingredients that were non-existent.

11 Jan 2011

SciClone initiates phase 2b study of SCV-O7 for oral mucositis

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) -- a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.

11 Jan 2011

Race, ethnicity and geography influence colon cancer screening

New research from UC Davis Cancer Center has found that whether a person gets screened for colon cancer often depends on where they live in addition to their race or ethnicity.

11 Jan 2011

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Eli Lilly and Company and Boehringer Ingelheim today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

11 Jan 2011

Survey reveals rise in Americans' concern over privacy of genetic information

A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).

11 Jan 2011

BiAqua, DSM enter partnership for strain and process development of BiAqua Ferritin

DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., an innovator in delivering bio-based solutions for serious water contamination issues, today announced that they have entered into an agreement for strain development, process development and production of "BiAqua Ferritin" for BiAqua's core technology to address bio-fouling and arsenic contamination in the water sector.

11 Jan 2011

European CE Mark approval for IntraPace's abiliti system

IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.

11 Jan 2011

Teenagers who consume excess sugar may face risk of developing heart disease

Teenagers who consume a lot of added sugars in soft drinks and foods may have poor cholesterol profiles — which may possibly lead to heart disease in adulthood, according to first-of-its-kind research reported in Circulation: Journal of the American Heart Association.

11 Jan 2011

NPS completes treatment phase in GATTEX Phase 3 registration study in short bowel syndrome

NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).

11 Jan 2011

Aid groups, U.N., U.S. discuss response to Haiti's earthquake as year anniversary approaches

On Friday, the Office of the U.N. Special Envoy to Haiti said that 63.6 percent of the aid international donors "pledged to Haiti in 2010 after a devastating earthquake nearly one year ago" has been disbursed, Deutsche Presse-Agentur/M&C reports (1/7).

11 Jan 2011

Floods may become a healthcare challenge, warns the AMA

The Australian Medical Association (AMA) has issued warnings to the Queensland health authorities to prepare for the rise of illnesses and injuries caused by the floods.

10 Jan 2011

Neuroptix announces closing of $4 million Series C funding round

Neuroptix Corporation, a leading innovator in the early detection of Alzheimer's Disease through a non-invasive eye test, today announced that it has closed the first approximately $4 Million tranche of a Series C funding round, as the company continues clinical development of its diagnostic platform.

10 Jan 2011

Professor Puchta receives ERC's Advanced Researcher Grant

Tomatoes that resist pests and extreme weather while still tasting like tomatoes are among Professor Holger Puchtas long-term research goals. The molecular biologist develops techniques that will allow him to control inheritance in plants to selectively improve the properties of different species through nature's existing gene pool. For his fundamental research, Puchta now is awarded an Advanced Researcher Grant by the European Research Council.

10 Jan 2011

Positive PK study results from ECLIPSE trial against cardiovascular disease

Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.

10 Jan 2011

Carrots and plums for better looks!

Researchers at St Andrews and Bristol universities have found that carrots and plums could make one more attractive in just two months. They found that these fruits and vegetables contain pigments called carotenoids that color the skin within two months making a person more attractive and healthy.

9 Jan 2011

PCPs and kidney specialists favor collaborative care for progressive chronic kidney disease

Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.

7 Jan 2011

CORE Health Centers is now Inspire Health

On January 7th CORE Health Centers, LLC: a distinguished outpatient, multi-disciplinary, weight management treatment center in the Chicago area, officially changed its name to Inspire Health. The change to Inspire Health more accurately reflects its mission of providing effective psychological and physiological treatments for healthy weight loss and management.

7 Jan 2011